AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2024
Jan 24, 2024
284_dirs_2024-01-24_3bbd8ecf-5b85-4a6c-ba04-f01d5b80fea9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2024-01-22
Reporting Person: Klobuchar Michael A (EVP - Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-22 | Common Stock | A | 3896 | $119.43 | Acquired | 23098.138 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6.292 | Indirect |
| Common Stock | 6.292 | Indirect |
| Common Stock - 401(k) Plan | 862.033 | Indirect |
| Common Stock - 401(k) Plan | 693.8675 | Indirect |
Footnotes
F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023.
F2: Holdings include shares acquired in dividend reinvestment transactions.
F3: Includes shares acquired and dividends earned through January 8, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30